Terumo Europe N.V.
31
1
3
18
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.1%
5 terminated/withdrawn out of 31 trials
78.3%
-8.2% vs industry average
6%
2 trials in Phase 3/4
0%
0 of 18 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (31)
Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma
Role: collaborator
Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma.
Role: lead
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
Role: lead
BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Role: lead
Treatment of Patients With Lesions in the Superficial Femoral and/ or Popliteal Arteries Using Kanshas Paclitaxel-coated Balloon Catheter.
Role: lead
Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease
Role: lead
Safety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular Carcinoma
Role: collaborator
Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE)
Role: lead
Prospective Single Arm CAS - ROADSAVER Study
Role: lead
Occlusafe® Assisted MW Alone or With DEB-TACE Compared to MW With DEB-TACE in the Treatment of HCC
Role: collaborator
Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study
Role: lead
Holmium-166 Retrospective Collection of Real-World Data
Role: lead
DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention
Role: lead
BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.
Role: lead
QuiremSpheres Observational Study
Role: lead
Complex Large-bore Radial Percutaneous Coronary Intervention (PCI) Trial
Role: collaborator
LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry)
Role: lead
LifePearl-Doxo Pharmacokinetic (PK) Study
Role: lead
e-NOBORI Observational Registry of Nobori DES
Role: lead
Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease
Role: lead